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ABSTRACT

Many essential oils and their components are known to have antimicrobial
activity. However, their strong aroma, flavor, and hydrophobic nature make them difficult
to incorporate into food products. New methods to improve antimicrobial activity at
reduced concentrations and/or reduce the influence of food components on
antimicrobial activity are needed. In this study, the objective was to combine the
emulsifier soy lecithin with eugenol in an attempt to enhance the activity of the latter
against the foodborne pathogen Escherichia coli O157:H7.
Eugenol was added to a pH 7.2 sodium phosphate buffer (PBS), PBS with 0.03%
(v/v) tryptic soy broth (TSB), PBS with 0.3% TSB, PBS with 0.6% TSB or PBS with
0.9% TSB and lecithin solution (0.0025, 0.005, 0.010, or 0.015% (w/v)) and
homogenized at 10,000 rpm for 3 min. An overnight culture of Escherichia coli O157:H7
was added and survivors enumerated at 0, 1, 3, 6, 12, and 24 h on tryptic soy agar
(TSA) incubated for 24 h at 37°C. The effect of varying microbiological media
concentrations (0.03-0.09% w/v) on lecithin interaction with eugenol was also evaluated.
In buffer with 550 ppm of eugenol, 0.01% lecithin slightly increased the
effectiveness of eugenol (P<0.05) while 0.0025, 0.005, and 0.015% samples did not
differ from the control. When 600 ppm of eugenol was used, the samples containing
0.0025% and 0.015% lecithin slightly increased the antibacterial activity of eugenol
(P<0.05) while 0.005, 0.005, and 0.010% lecithin had no significant effect (P<0.05). At
650 ppm of eugenol, there was no significant difference (P<0.05) between the control
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and the lecithin containing samples. In 0.03% TSB, the presence of 0.01% lecithin
significantly increased the antibacterial activity of eugenol at both 550 and 650 ppm
while 0.1% lecithin significantly decreased the activity. In 0.3% TSB, only minor
differences were found while in 0.9% tryptic soy broth (TSB), the antimicrobial activity of
eugenol was essentially eliminated except for a 1 log CFU/ml reduction in the presence
of 0.01% (but not 0.1%) lecithin. Overall, lower concentrations of lecithin improved the
antimicrobial properties of eugenol when media concentrations were low indicating
interactions between the lecithin, eugenol and microbiological media.
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CHAPTER I
INTRODUCTION
Foodborne illnesses remain a major issue across the United States despite
advances in food safety and processing technologies. The Centers for Disease Control
and Prevention report that 1 in 6 Americans suffer from a food related illness every year
(62). One potential method for improving food safety would be to add antimicrobials to
foods to prevent growth of or inactivate foodborne pathogens. While consumers
demand safe and wholesome foods, their acceptance of traditional antimicrobials is
declining. As a result, the food industry as a whole is increasingly seeking out labelfriendly antimicrobials. A potential solution for the food industry lies in the use of
antimicrobials that come from natural sources and do not need to be labeled as
synthetic chemical preservatives (75).
Essential oils (EOs) and their components are known to have antimicrobial
properties and are considered natural which may be appealing to consumers. Their
Generally Recognized as Safe (GRAS) classification makes them desirable to food
manufacturers. Because of these properties, EOs have the potential to serve as novel
antimicrobial preservatives in food industry. However, in many cases a high
concentration, usually over 500 ppm, of the EOs or EO components are needed to
inhibit foodborne pathogens (18). These relatively high concentrations make them
unsuitable for use in many food products due to strong flavor and aroma characteristics.
If the antimicrobial activity of EOs and EO components can be increased, use in the
industry as natural food preservatives may be possible.
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Eugenol, an EO component of cloves is known to have broad spectrum
antibacterial properties. It has been shown by some research that EOs in emulsions
may have better activity in foods than free EOs. For example, in a previous study, Li
(46) found that the antimicrobial activity of eugenol against Escherichia coli O157:H7
was increased in the presence of certain concentrations of lecithin. The inactivation rate
as measured by D-value (time to decrease the viable population by 90%) in the
presence of eugenol decreased from ca. 4.0 min to 1.2 min in the presence of 0.0025%
(w/v) lecithin (46). What made the study unique was that at concentrations above
0.0025% lecithin, the D-value increased indicating the potential for an optimum level of
lecithin for inactivation. The purpose of the present study was to further investigate if the
addition of the emulsifier, soy lecithin, to eugenol was could serve to stabilize the
emulsion and increase the antibacterial activity of free eugenol.
The objectives of this study were (1) to determine whether the previous results
could be replicated, and (2) what effect time of exposure, lecithin concentration, and
concentration of microbiological media had on the antibacterial activity of eugenol
against E. coli O157:H7.
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CHAPTER II
LITERATURE REVIEW
Escherichia coli O157:H7
Background
Escherichia coli are Gram-negative, rod-shaped bacteria that ferment lactose
with the production of gas in 48 h at 35°C making them members of the coliform group
of bacteria as well as Enterobacteriaceae. There exist strains of E. coli that are
pathogenic or non-pathogenic. The pathogenic types are enteropathogenic (EPEC),
enterotoxigenic (ETEC), enteroinvasive (EIEC), enteroaggregative (EAEC) and
enterohemorrhagic (EHEC). Serotype Escherichia coli O157:H7 was the first EHEC
recognized as a foodborne pathogen when it was isolated in 1982 from four patients in
Oregon and Michigan who had eaten undercooked meat from a fast food restaurant
chain (49, 60).
The optimum growth temperature for this bacteria is 37°C with an upper limit of
44 to 45°C and a minimum of 8°C (40). It grows well at pH 5.5 to 7.5 but the growth rate
declines heavily at lower pH values with a minimum growth pH between pH 4 and 4.5
(16, 17). In food products under the minimum growth pH, E. coli O157:H7 can survive
for weeks or months with increased survival in refrigeration temperatures (15).
Cattle are a common reservoir of E. coli O157:H7 (74). Young cows more
frequently carry the bacterial than adult animals. A survey of cattle herds in the United
States found an incidence rate of 3.2% among dairy calves (74). The E. coli population
being shed by the calves was between <102 and 105 CFU/g (15). E. coli O157:H7 is
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found inside the gastrointestinal tract of cattle, particularly in the fore stomachs, distal
ileum, proximal cecum, spinal colon, and descending colon (15). Transmission to
humans is most commonly associated with raw beef and milk, but it has been identified
in a multitude of different food products including fruit, vegetables, juice, and water (24,
49, 68)
Pathogenesis
E. coli’s ability to produce Shiga toxins greatly contributes to its ability to cause
disease (47). Both Shiga toxin 1 and 2 are produced by E. coli O157:H7 but Shiga toxin
2 is more often associated with severe illness (48). This toxin can lead to hemolytic
uremic syndrome, hemorrhagic colitis, kidney damage, and death in severe cases (28,
48). The toxin passes through the epithelium of the intestines and disrupts the epithelial
cells which line the blood vessels that connect to the kidneys (69). Illness can occur
between 1 and 8 days after exposure with an average incubation period of 3 days (49).
Symptoms can include diarrhea, vomiting, fever, abdominal pain (49, 67).
Outbreaks
E. coli O157:H7 is the most commonly isolated enterohemorrhagic serotype of E.
coli in several countries including the United States (47). It is estimated that E. coli
O157:H7 infections cause 63,000 illnesses and 20 deaths in the United States annually
(62). These infections cost an estimated 255 million dollars annually in 2009 dollars
(38). While the annual number of Salmonella and Campylobacter cases exceed the
number of E. coli O157:H7 cases annually, the fatality rates and hospitality rates of E.
coli are much higher (47).
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Since 2011, there have been 6 multistate outbreaks of E. coli O157:H7 reported
by the Centers for Disease Control (11). In 2014, a four state outbreak was traced to a
Detroit meat packing plant and caused sickness in at least 12 people in four states (3,
10). Of the 12 confirmed cases, all reported eating a hamburger at a restaurant and 8
stated that they had eaten an undercooked hamburger, rare or medium-rare, days
before symptoms began (3). In 2013, an outbreak associated with ready-to eat salads
infected at least 33 people in four states (9). Romaine lettuce was determined to be the
cause of the outbreak and it was believed the lettuce became contaminated at the farm
level through wind transfer or from contaminated farm equipment (2). In 2012, 33
infections were reported in 5 states (8). This outbreak was traced to a single producer
but the cause of the contamination is not known (8). In 2011, three multistate outbreaks
were reported. The first involved 60 people in 10 states who were affected by an
outbreak traced to romaine lettuce (6). The second outbreak affected 14 people in 5
states and was traced to store bought bologna (5). The third multistate outbreak in 2011
involved 8 people in 3 states and was caused by in-shell hazelnuts (7).
Control Measures
Apple cider and other fruit juices are have been associated with E. coli O157:H7
infections due to the high acid resistance and low infectious dose of E. coli (44). This
pathogen is also able to survive for long periods of time in refrigeration temperatures
(73). Juices can become contaminated due to contact with contaminated soil, water, or
employees. The Food and Drug Association has a 5-Log Reduction Performance
Standard in place for fruit and vegetable juices. According to this standard, juice
products must be treated so that the population of the pertinent pathogen, frequently
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Escherichia coli O157:H7, is reduced by 5 logs in order to comply with the Hazard
Analysis and Critical Control Point (HACCP) requirements (4).
Heat treatment is often used to control E. coli O157:H7 in food products. This
includes pasteurization of liquid products and cooking of solid products to a temperature
of 68.3˚C for 15 seconds (42). However, heat treatment is not an option for all food
products and may actually reduce the nutritional quality and flavor of some products
such as apple cider (44). Additionally, pasteurization processing and materials are also
very expensive. Therefore, non-thermal methods of control could be very beneficial to
the food industry.
Essential Oils
Background
Spices are defined as aromatic or fragrant plant products which can be used to
impact flavor, aroma, or color to food products (22, 37). Herbs are generally defined as
leaves and flowering portions of soft-stemmed plants which are used to season food
products (22). Typically, herbs and spices are obtained from the fruit, seeds, rhizomes,
roots, leaves, bark, flower, or bulb portion of a plant (22). The principal flavoring
components of spices are essential oils (58).
Properties
Essential oils are defined as oily liquids which are obtained from aromatic plant
materials (18). Each oil can contain 20 to 60 components in various concentrations with
two or three components typically found in high concentrations, between 20 and 70%,
and the rest being found in trace amounts (12). The major components of essential oils
are generally divided into four categories based on their chemical structures. These
6

categories are terpenes, terpenoids, phenylpropenes, and other (39). Terpenes are
primarily responsible for the aroma of essential oils and consist of 5 carbon isoprene
units (1, 39). Terpenoids are partially responsible for the flavor and aroma
characteristics of essential oils and they consist of repeating branched five carbon units
with an isopentance skeleton (54). Phenylpropenes have a six carbon aromatic phenol
group (39). Essential oils are produced by plants to provide protection from
microorganisms and insects and are extracted from several different areas of plants
including leaves, bark, flowers, and seeds (51, 57).
Many essential oil components have been shown to have antibacterial and
antifungal properties. The antimicrobial activity of these components is heavily
influenced by their hydrophobicity which improves their ability to solubilize and disrupt
the phospholipid bilayers of cytoplasmic membranes (45). The structure of essential oil
compounds greatly impacts its ability to disrupt cytoplasmic membranes. The presence
of a free -OH group in essential oil compounds, such as carvacrol and thymol, is
believed to contribute to the EOs ability to disrupt the cytoplasmic membrane (45).
Eugenol’s hydroxyl group is believed to bind to and interact with proteins (39). In
eugenol, EO components such as phenolic alcohol, aldehydes, or ketones are also
effective antibacterial agents (45). Phenolic compounds have the ability to disrupt the
cytoplasmic membrane, proton motive force, electron flow, and active transport (18).
Phenolic compounds may also cause a microorganism to alter its fatty acid or
phospholipid composition in the cytoplasmic membrane which may result in a disruption
in nucleic acid synthesis, nutrient uptake, and electron transport (25).
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In general, Gram-negative bacteria are less susceptible to EOs than Grampositive bacteria (30). This is due to the presence of lipopolysaccharides in the outer
cell membrane which, because of their hydrophilic nature, provide an increased
tolerance for hydrophobic compounds such as those found in essential oils (39, 52).
Extraction Methods
Essential oils can be extracted from plants by several different methods including
steam distillation, solvent extraction, and supercritical fluid extraction (13). Steam
distillation is the most commonly used commercial method. In this method, selected
parts of the plant are heated with hot water or steam. The heat causes the cell
structures to break down and releases the essential oils which are volatilized and
collected via distillation (70). Solvent extraction is more often used for delicate flower
materials or fragile plant components which are not resistant to heat or steam treatment
(70). For this process, acetone, hexane, petroleum ether, methanol, or ethanol is added
to the selected plant material and it is heated to extract the essential oil. The
temperature for this process varies by technique with the accelerated solvent extraction
technique requiring temperatures ranging from 50 to 180°C (41). The filtrate is then
concentrated using solvent evaporation. Alcohol is mixed with the concentrate and the
mixture is distilled at a low temperature which allows the alcohol to absorb the fragrance
(70). When the alcohol evaporates, the absolute oil remains (70). To perform
supercritical carbon dioxide extraction, carbon dioxide is exposed to high-pressure,
about 72 bar, which causes it to take a liquid form (41). Supercritical carbon dioxide is
useful because it can penetrate cellular matrices to extract the EO components which
are very soluble in it (41, 70). When this is complete, the pressure is returned to normal
8

atmospheric conditions, around 1 bar, and the carbon dioxide then reverts to its gas
form and evaporates leaving the essential oil compounds (41, 70). Carbon dioxide is a
good solvent for this extraction because it has a low toxicity, is easy to separate from
the extracted compounds, and has a low cost (34, 76).
Use in Food Industry
EOs are primarily used in the food industry to add desirable flavors and/or
aromas to food products (53). US FDA regulations classify these compounds as
generally recognized as safe (GRAS) for use in foods. Because they are GRAS and are
considered “natural” additives, the food industry has great interest in EOs for uses other
than their contribution to flavors, such as use as antimicrobials and antioxidants. This is
because of a growing consumer demand for food products with “less processing” and
more “natural” ingredients (61). Thus, EOs have been investigated and actually applied
as food preservatives due to their antibacterial and antifungal capabilities (23, 53).
Eugenol as an Antimicrobial Compound
Properties
Eugenol (Figure 1) belongs to the phenylpropanoid class of compounds. It is the
major component of several oils including allspice, basil, and clove and makes up
approximately 84% of clove EO and 72% of cinnamon leaf EO (20, 51). This oily
substance is typically a clear or pale yellow color (71). Eugenol has a molecular weight
of 164.2 and is partially hydrophobic (31, 43).
Antibacterial Activity
Eugenol is a particularly effective essential oil against foodborne pathogens such
as E. coli due to the amount of phenolic compounds it possesses. It has the ability to
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penetrate the cellular membranes of bacteria and cause ATP and potassium to leak
from the cell (32, 35, 39, 72). It has been found to inhibit amylase and protease
production in Bacillus cereus and contributed to the deterioration of the cell wall and the
inhibition of enzyme activity in Enterobacter aerogenes (71). The antimicrobial activity of
eugenol against the Gram-negative bacteria Proteus mirabilis is due to its ability to bind
to the cytoplasmic membrane of the bacterium and make it more permeable (27).
Additionally, eugenol can cause pores to form in the plasma membrane of bacteria
which causes intracellular proteins to be released (27).
Sensory Characteristics
Essential oils are frequently used in the food industry to impart flavor and aroma
characteristics to food products (39). The concentration of essential oils required to act
as preservative agents in food, however, is much higher. In order to achieve
antimicrobial activity in food products, concentrations over 500 ppm must be used for
many products (18, 66). At that concentration, however, major changes to the sensory
characteristics of food products will likely make the product unacceptable to consumers.
In a recent study, the tolerance limit for carvacrol, thyme, and rosemary essential oils
was found to be 20 ppm or less when tested on a hedonic scale in tomato juice and
vegetable juice (29). Many spice components, including eugenol, contribute a bitter or
pungent taste to food (36).
Enhancing Antimicrobial Effectiveness of Eugenol and other EO components
EO components, while effective against a variety of bacteria, are difficult to
incorporate into food products. This is due to their hydrophobic nature and because of
the complex nature of food. EO components may react with hydrophobic food
10

components which reduces their activity. Because of this, a high concentration of EO or
EO components is required which may lead to potential sensory problems. Therefore,
the effectiveness of EOs must be increased so that a lower, and more commercially
acceptable, amount can be used. The use of limiting intrinsic and/or extrinsic factors for
foods along with reduced concentration EO treatments could potentially be used as
preservation hurdle technologies. These limiting factors may include pH, temperature,
atmosphere, combinations of EO components or and the use of compounds such as
emulsifiers to enhance antimicrobial activity. Hurdle technology is the combination of
two or more preservation parameters which creates maximum control against
microorganisms while preserving the sensory characteristics of the product (64).
One potential method to enhance EO effectiveness is to adjust the pH of the
environment. The effectiveness of essential oil components in different pH
environments has been evaluated. Several essential oils and components were tested
at pH 7.2, 4 and 4.5. The minimum inhibitory concentration (MIC) of eugenol was 0.05%
v/v against E. coli O157:H7 at pH 7.2. When the pH was reduced to 4.5, the MIC
decreased to 0.025% and at pH 4 the MIC was reduced to <0.0031% v/v. Additionally,
the minimum bactericidal concentration at pH 7.2 was 0.1% and was decreased to 0.05
at pH 4 (55). Temperature may also contribute to the effectiveness of EOs. EOs were
found to be more effective at room temperature in one study due to the changes in
membrane fluidity (59). At low temperatures, the phospholipids in the membrane are
more closely packed together forming a rigid gel structure. At higher temperatures, the
phospholipids are less tightly packed and the membrane has a liquid-crystalline
structure (59). Combinations of essential oil components have increased the
11

antibacterial effects against some microorganisms. The minimal inhibitory concentration
against E. coli CGMCC 1.487 was decreased form approximately 1600 ppm to 400 ppm
when treated with a combination of cinnamaldehyde, thymol, or carvacrol (56).
The inclusion of emulsifiers on the activity of EOs has been evaluated
extensively, either for their potential enhancement or for producing water soluble microor nanoparticles. In one study, researchers combined EOs with lecithin and agar
stabilizers. When 0.25% (w/v) lecithin was tested in combination with oregano oil and
thyme oil, the antibacterial properties of the EOs against E. coli O157:H7 was greatly
reduced. It was proposed by the authors that the lecithin interfered with the ability of the
essential oils to physically interact with the cells of the bacteria (19). When combined
with 0.05% agar, the antibacterial properties of EOs was significantly increased.
Researchers believe this is due to less rapid separation of the essential oil components
from the water phase or because the ability of the essential oil component to interact
with the phospholipids in the outer layer of the bacteria was neutralized by the additional
presence of phospholipids in lecithin (19).
Lecithin
Background
Lecithin (Figure 2) is widely used in the food industry as an emulsifier, wetting
agent, release agent, anti-spatter agent, and phosphate dispersant (65). It contains a
mixture of phospholipids including phosphatidylcholine, phosphatidylethanolamine,
phosphatidylinositol, phosphatidic acid, phosphatidyl serine, and lysophosphatides
Lecithin can be produced from many sources of living matter including plant,
animal, and microbial sources (63). It was first derived from egg yolk but it is now more
12

commonly recovered from plant sources including cottonseed, peanuts, sunflower
seeds, sesame seeds, flax seed, and soybeans (21). For commercial use, lecithin
derived from vegetable oil, primarily soybeans, is the most common (21).Soybean
lecithin, on average, contains about 35% soybean oil, 18% phosphatidylcholine, 15%
phosphatidylethanolamine, 11% phosphatidylinositol, 9% other phosphatides, and 12 %
carbohydrates (50). Commercial soybean lecithin is typically obtained as a by-product of
vegetable oil production. Several methods can be used to extract lecithin from soybeans
including hydraulic pressing, screw pressing, prepress solvent extraction, and direct
solvent extraction (21).
Use in Food Industry
Lecithin obtained from vegetable sources has GRAS regulatory status in the
United States (63). With modification, lecithin can be used in both oil-in-water and
water-in-oil emulsions (26). The emulsification properties of lecithin are largely due to
the presence of phospholipids, the main component of lecithin. These phospholipids are
partly hydrophobic (non-polar) and partly hydrophilic (polar) (33). The hydrophilic portion
is soluble in water while the hydrophobic portion is soluble in oil (14). To create an
emulsion, the emulsifier orients at the boundary between two immiscible liquids with the
hydrophobic portion in the oil phase and the hydrophilic portion in the water phase (14)
thereby stabilizing it.
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CHAPTER III
MATERIALS AND METHODS
Bacterial Strain
E. coli O157:H7 strain ATCC 43889 was obtained from the Department of Food
Science at the University of Tennessee. This was grown in tryptic soy broth (TSB; Difco,
Sparks, MD) at 37°C for 24 h, combined with glycerol, and kept at 0°C. Working cultures
were created by inoculating 10 ml of TSB and incubating for 24 h at 37°C.
Eugenol-Lecithin Preparations
Eugenol (4-allyl-2-methoxyphenol, 99%) was obtained from Acros Organics
(Fairlawn, NJ) and lecithin (soybean lecithin, >99%) was obtained from Fisher Scientific
(Fairlawn, NJ).
To replicate the original experiments on which this study was based, the
concentration of eugenol was 800 ppm, the concentrations of lecithin used ranged from
0.001 to 0.015% w/v, the suspension medium was 0.5% TSB (based upon carryover of
medium from the culture), and the time of exposure was 0 to 30 min.
For the initial experiments, (0.5% w/v TSB), lecithin concentrations ranged from
0.001% w/v to 0.015% w/v. Lecithin was added to 0.1M sodium phosphate buffer (pH
7.2) which had been sterilized at 121°C for 15 min using an autoclave. The lecithin in
buffer mixture was stirred continuously while heating to boiling (ca. 100°C) for 5 min to
dissolve the lecithin. Distilled water was added to the solution to replace the water lost
during boiling (about 3% of total volume). To prepare emulsions, 800 ppm eugenol was
added to stock lecithin buffer solutions in 125 ml Erlenmeyer flasks and samples were
14

then homogenized at 10,000 rpm using a Polytron PY 10/35 homogenizer (Kinematica,
Inc., Bohemia New York) for 3 min at room temperature (46).
For the next set of experiments in 0.03%, 0.3%, 0.6% and 0.9% (w/v) TSB,
lecithin was added at concentrations ranging from 0.001% w/v to 0.015% w/v. Lecithin
was added to 0.1M sodium phosphate buffer (pH 7.2) which had been sterilized at
121°C for 15 min using an autoclave. The lecithin in buffer mixture was stirred
continuously while heating to boiling (ca. 100°C) for 5 min to dissolve the lecithin.
Distilled water was added to the solution to replace the water lost during boiling (about
3% of total volume). To prepare emulsions, 550, 600 or 650 ppm eugenol was added to
stock lecithin buffer solutions in 125 ml Erlenmeyer flasks and samples were then
homogenized at 10,000 rpm using a homogenizer (Polytron, Kinematica) for 3 min (46).
Inactivation Experiments
A 24 h culture of E. coli O157 that had been grown at 37°C was then added to
each flask containing eugenol-lecithin mixtures. Flasks were incubated statically at 25°C
and a sample was removed from each flask at 0, 1, 3, 6, 12, and 24 h to enumerate E.
coli O157. Samples were serially diluted using 0.1% peptone water (Difco) and spread
plated in duplicate on tryptic soy agar (TSA; Difco). TSA plates were incubated for 24 h
at 37°C and the log CFU/ml was calculated for each sample.
For samples containing 0.03% w/v media, 99 ml of the lecithin, eugenol, and
phosphate buffer solution were added to a flask and 1 ml of an overnight (24 h) culture
of E. coli O157:H7 was added. For samples containing 0.3% w/v media, 90 ml of the
lecithin, eugenol, and phosphate buffer solution was added to the flask and 10 ml of an
overnight (24 h) culture of E. coli O157:H7 was added. For samples containing 0.6%
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w/v media, 80 ml of the lecithin, eugenol, and phosphate buffer solution was added to
the flask and 10 ml of an overnight (24 h) culture of E. coli O157:H7 was added. Then
10 ml of sterile TSB broth was added. For samples containing 0.9% w/v media, 70 ml of
the lecithin, eugenol, and phosphate buffer solution was added to the flask and 10 ml of
an overnight (24 h) culture of E. coli O157:H7 was added. Then 20 ml of sterile TSB
broth was added.
Effect of Time
In the present experiments, the maximum incubation times evaluated initially
were 30 min but were lengthened to 24 h for subsequent experiments.
Statistics
Each experiment was repeated three times. Analysis of variance was conducted
using version 9.4 of Statistical Analysis Software. Least significant differences were
used to compare treatments and significant difference was defined as P<0.05.
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CHAPTER IV
RESULTS AND DISCUSSION
In initial testing, 800 ppm of eugenol was combined with 0 to 0.015% lecithin in
buffer containing 0.03% TSB and E. coli O157:H7 was exposed for 30 min (Fig. 3).
Lecithin (0.001, 0.0025, 0.005, 0.005, and 0.015% w/v) did have a significant effect on
increasing the activity of eugenol compared to the control (P< 0.05) after 30 min but
reductions were only ca. 1 log CFU/ml. The concentration of lecithin did not appear to
have any relationship to the extent of inhibition as was reported in a previous study
where 0.0025% lecithin was found to be an “optimum” level for inactivation (46). Since
the findings of Li (46) could not be replicated, the effect of eugenol and lecithin
concentrations, time, and microbial media concentration were investigated further.
The first thing evaluated was the antimicrobial effect of lecithin itself. The addition
of soy lecithin alone (0.0025 to 0.015%) in 0.3% TSB had no antimicrobial effect on E.
coli O157:H7 after 24 h (P<0.05) (Fig. 4). There also was no significant reduction
(P<0.05) in the population of E .coli O157:H7 after 24 h in the control buffer.
Next the effects of varying concentrations of eugenol (550-650 ppm) and the
presence of microbiological medium (0.03-0.9%) in the phosphate buffer on the
antimicrobial activity against E. coli O157:H7 was determined (Fig. 5-7). In the
experiments performed by Li (46), 10 ml of an overnight E. coli culture in TSB was
added to 45 ml of lecithin and phosphate buffer solution. This resulted in a total TSB
concentration of 0.5% w/v in each sample. In order to determine whether
microbiological media concentration had an effect on the antibacterial properties of
eugenol and lecithin, 0.03% w/v, 0.3% w/v, 0.6% w/v, and 0.6% w/v media were added
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to the lecithin-eugenol mixtures and the inactivation experiment was repeated. At 550
ppm eugenol, there was no reduction (< 1 log CFU/ml) in viable E. coli O157:H7 nor any
significant differences between 0.6 and 0.9% media (P<0.05) (Fig. 5). When the media
concentration was reduced to 0.3%, E. coli O157:H7 was significantly lower (P<0.05)
than 0.6 and 0.9% media but the average log reduction was only 1.72 log CFU/ml. At
0.03% media, a smaller volume of culture reduced the initial count by 1 log but the
reduction after 24 h was much greater at ca. 4.9 log CFU/ml compared to 0.6 and 0.9%.
Similarly to 550 ppm, at 600 ppm eugenol there was no reduction (< 1 log CFU/ml) in
viable E. coli O157:H7 nor any significant differences between 0.6 and 0.9% media (Fig.
6). When the media concentration was reduced to 0.3%, E. coli O157:H7 counts were
significantly lower (P<0.05) than 0.6 and 0.9% media with an average log reduction of
1.83 log CFU/ml. At 0.03% media, a smaller volume of culture reduced the initial count
by 1 log. After 24 h of incubation there was a very large decrease in viable counts of ca.
7 log CFU/ml compared to the 0.6 and 0.9% media. At 650 ppm eugenol, there was no
reduction (< 1 log CFU/ml) in viable E. coli O157:H7 nor any significant differences
between 0.6 and 0.9% media (Fig. 7). When the media concentration was reduced to
0.3%, E. coli O157:H7 showed an average log reduction of 4.8 log CFU/ml which was
significantly lower (P<0.05) than 0.6 and 0.9% media. At 0.03% media, the reduction
after 24 h was ca. 7 log CFU/ml compared to 0.6 and 0.9% media. Overall, it was
evident that TSB had significantly negative effect on the antimicrobial activity of eugenol
against E. coli O157:H7.
Next, the interactive effects of varying concentrations of eugenol (550, 600, and
650 ppm) with lecithin (0.0025, 0.005, 0.01, and 0.015% w/v) in phosphate buffer on the
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antimicrobial activity of eugenol against E. coli O157:H7 was determined (Fig. 8-10). At
550 ppm eugenol, there was no significant difference between 0.0025, 0.005, and
0.015% lecithin compared to 0% lecithin (Fig. 8). All showed an average of 1.7 log
CFU/ml reduction (P<0.05). When the lecithin concentration was 0.010% w/v, E. coli
O157:H7 counts were significantly lower (P<0.05) with an average reduction of 3.07 log
CFU/ml after 24 h. At 600 ppm, there was no significant difference in viable E. coli
O157:H7 counts between 0.005 and 0.01% lecithin compared to 0% lecithin (1.8 log
CFU/ml reduction) (P<0.05) (Fig. 9). At 0.0025 and 0.015% w/v lecithin, E. coli counts
were significantly lower (P<0.025) than 0% lecithin with an average log reductions of
2.80 log CFU/ml and 3.51 log CFU/ml, respectively, after 24 h. 650 ppm eugenol with
no lecithin was lethal to the E. coli O157:H7 with a reduction of nearly 5 log CFU/ml
after 24 h (Fig. 10). The addition of soy lecithin (0.0025, 0.005, 0.010, and 0.015% w/v)
had no additional antimicrobial effect on E. coli O157:H7 and, in fact, 0.0025% was
antagonistic. Therefore, while higher concentrations of eugenol caused greater
reduction of viable E. coli O157:H7, the lecithin either had no effect or the effect was not
related to concentration.
The influence of media concentration on interaction between eugenol and lecithin
was evaluated by reducing the concentration of TSB to 0.03%. Eugenol was tested at
550 or 650 ppm and lecithin was tested at 0.01 or 0.1% w/v (Fig.11-12). With 550 ppm
eugenol and no lecithin, the reduction in viable counts of ca. 4 log CFU/ml after 24 h in
0.03% TSB (Fig. 11) was much larger than that the 1.5 log CFU/ml reduction after 24 h
seen in 0.3% TSB (Fig. 8). When the lecithin concentration was 0.1% w/v, viable E. coli
O157:H7 were significantly higher (P<0.05) than the 0% lecithin control with an average
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log reduction of ca. 2.3 log CFU/ml. When the lecithin concentration was reduced to
0.01%, at 24 h viable cells of E. coli O157:H7 were significantly reduced by an average
6.73 log CFU/ml compared to time 0 which was significantly lower (P<0.05) than 0%
lecithin. Increasing the eugenol concentration to 650 ppm enhanced inactivation under
all test conditions compared to 550 ppm but the pattern was very similar with 0.01%
lecithin dramatically increasing the inactivation of eugenol while 0.1% had an
antagonistic effect (Fig. 12). With 0.1% w/v lecithin, E. coli O157:H7 counts were
significantly higher (P<0.05) than 0% lecithin at 24 h. After 24 h, the populations of E.
coli O157:H7 in both the 0% and 0.01% lecithin samples were below the detection limit
of 1 log CFU/ml. Thus, it was again evident that TSB concentration had a very large
impact on the antimicrobial activity of eugenol and lecithin with higher concentrations
reducing activity. In addition, at lower TSB concentrations, higher concentrations of
lecithin negatively impacted eugenol antimicrobial activity against E. coli O157:H7. This
was further confirmed by evaluating the compounds in 0.9% TSB (Fig. 13-14). Here the
effect of 550 or 650 ppm eugenol 0.01 or 0.1% lecithin were evaluated for their
antimicrobial activity against E. coli O157:H7. As with 0.3% media (Fig. 8), neither 550
ppm eugenol alone or in combination with either concentration of soy lecithin had any
antimicrobial effect on E. coli O157:H7 after 24 h (P<0.05) (Fig. 13). Similarly, at 650
ppm eugenol had no antimicrobial activity on E. coli O157:H7 after 24 h by itself nor with
addition of 0.1% w/v lecithin (P<0.05) (Fig. 14). When the concentration of lecithin was
decreased to 0.01% w/v, viable E. coli O157:H7 was significantly reduced (P<0.05)
compared to the 0 and 0.1% lecithin with an average log reduction of 1.45 log CFU/ml.
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Overall, a reduction of the antimicrobial activity of eugenol in the presence of
0.1% lecithin was consistent with the findings of Burt and Reinders (19). They showed
that the addition of 0.25% lecithin greatly reduced the antibacterial properties of
oregano, thyme oil light and thyme oil red against E. coli O157:H7 (19). This reduction
was likely due to the lecithin physically impeding contact of the oil with the bacteria or
because the EO activity against the phospholipids in the bacterial cell membrane was
limited due to the interaction of the EO with the phospholipids present in soy lecithin
(19).
It was apparent that media concentration affected the antimicrobial activity of the
eugenol and the eugenol-lecithin combinations. For example, 0.01% lecithin significantly
reduced the effectiveness of eugenol in the presence of 0.9% media, had almost no
effect in the 0.3% media samples, and significantly increased the effectiveness of
eugenol in 0.03% media after 24 h. Based on the results of this study, enhancement of
eugenol antimicrobial activity against E. coli O157:H7 by an optimum concentration of
lecithin was demonstrated as was reported by Li (46). This may be due to differences in
TSB lots. As it was demonstrated in the present study, microbiological medium
concentration has a large influence on the antimicrobial activity of eugenol and lecithin,
and differences in the media could affect the interaction of lecithin and eugenol.
Additionally, differences in the E. coli culture handling and errors measuring such small
lecithin concentrations used by Li (46) may have influenced the results.
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CHAPTER V
CONCLUSIONS
The ability of soy lecithin to enhance the antimicrobial activity of eugenol appears
to be dependent on media concentration of the sample. In low media conditions, 0.01%
lecithin greatly increased the antibacterial activity. Therefore, lecithin is a promoter of
eugenol activity in limited situations. This is likely due to lecithin increasing the stability
of the emulsion which can slow the separation of the oil and the water phase and
improve the ability of eugenol to inhibit E. coli (19). In order to improve effectiveness,
the use of lecithin may be combined with other treatments to further increase the
antibacterial properties of essential oils.
Tryptic soy broth was found to have a significant effect on the antimicrobial
activity of eugenol and lecithin. Further studies should therefore determine how the
structure and nutrient availability of food products affects the effectiveness of eugenol
and lecithin in the absence or near absence of TSB.
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Figure 1 Structural Formula of Eugenol (from Hyldgaard and others (40))
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Figure 2 Molecular structure of phosphatidylcholine. R1 and R2 are alkyl chains (From Weland and Hartel (75))
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Figure 3 Average log population of E. coli O157:H7 with 0.5% w/v media, 800 ppm of eugenol, and varying lecithin
concentrations in phosphate buffer after 30 min.
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Figure 4 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin and 0.3% w/v media
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Figure 5 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of media and 550 ppm eugenol v/v

38

600 ppm Eugenol
9

Log Population (CFU/ml)

8
7
6
5

0.03% Media

4

0.3% Media

3

0.6% Media

2

0.9% Media

1
0
0

5

10

15

20

25

Time (Hour)
Figure 6 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of media and 600 ppm eugenol v/v
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Figure 7 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of media and 650 ppm eugenol v/v
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Figure 8 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.3% w/v media, and 550 ppm eugenol v/v
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Figure 9 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.3% w/v media, and 600 ppm eugenol v/v
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Figure 10 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.3% w/v media, and 650 ppm eugenol v/v
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Figure 11 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.03% w/v media, and 550 ppm eugenol v/v
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Figure 12 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.03% w/v media, and 650 ppm eugenol v/v
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Figure 13 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.9% w/v media, and 550 ppm eugenol v/v
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Figure 14 Average log population of Escherichia coli O157:H7 in sodium phosphate buffer (pH 7.2) with varying
amounts of soy lecithin, 0.9% media, and 650 ppm eugenol v/v
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